Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Microcyn Plus Skin and Wound Hydrogel

K-Number: K153648 · 2016-04-19

Decision Date2016-04-19
Product CodeFRO
DecisionSubstantially Equivalent

Device Summary

Microcyn Plus Skin and Wound Hydrogel is a medical device manufactured by Oculus Innovative Sciences. It received FDA 510(k) clearance on 2016-04-19 under approval number K153648. The device is classified under product code FRO. Product code FRO falls under the category of Anesthesiology, which includes devices for anesthetic delivery and patient monitoring. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Microcyn Plus Skin and Wound Hydrogel?

Microcyn Plus Skin and Wound Hydrogel is a medical device that received FDA 510(k) clearance on 2016-04-19. It is manufactured by Oculus Innovative Sciences. The 510(k) number is K153648.

When was Microcyn Plus Skin and Wound Hydrogel approved by the FDA?

Microcyn Plus Skin and Wound Hydrogel received FDA 510(k) clearance on 2016-04-19, under approval number K153648.

What company makes Microcyn Plus Skin and Wound Hydrogel?

Microcyn Plus Skin and Wound Hydrogel is manufactured by Oculus Innovative Sciences.

What is the FDA product code for Microcyn Plus Skin and Wound Hydrogel?

The FDA product code for Microcyn Plus Skin and Wound Hydrogel is FRO. This falls under the Anesthesiology category.

Related Clinical Trials

Related PubMed Literature

Other Devices by Oculus Innovative Sciences

Related Devices (Code: FRO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.